Immunic, Inc. is trading at $12.78 (0.1% down) today amid ongoing biotech and rates-related volatility as investors digest recent sector-wide risk sentiment shifts.
- The stock is essentially flat versus its last close, recovering from an 11.5% slide on June 5 through a sharp after-hours rebound.
- Current price action is attributed to macro jitters and broader industry trends rather than any new company-specific catalysts.
- Investors continue to monitor the equity as it stabilizes following significant price swings in previous sessions.